Avenue Therapeutics completes $3M share repurchase from InvaGen; two directors resign

AVENUE THERAPEUTICS, INC.

Completed $3M repurchase of InvaGen's 100% stake in Avenue, financed by public offering closed Oct 11, 2022.
Jaideep Gogtay, M.D. and E. Garrett Ingram resigned from Board and all committees effective Oct 31, 2022.
Resignations not due to any disagreement with Company, its operations, or management.
All rights granted to InvaGen under 2018 Stockholders Agreement terminated upon share repurchase.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Jaideep Gogtay, M.D.

Director

ATXI · AVENUE THERAPEUTICS, INC.

Effective: 2022-10-31
Filed: November 4, 2022, 7:59 PM ET

each of Jaideep Gogtay, M.D. and E. Garrett Ingram, the two non-independent members of the Board originally selected by InvaGen, resigned as members of the Board and all committees thereof, effective immediately.

Departed

E. Garrett Ingram

Director

ATXI · AVENUE THERAPEUTICS, INC.

Effective: 2022-10-31
Filed: November 4, 2022, 7:59 PM ET

each of Jaideep Gogtay, M.D. and E. Garrett Ingram, the two non-independent members of the Board originally selected by InvaGen, resigned as members of the Board and all committees thereof, effective immediately.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Jaideep Gogtay, M.D. resigned as Director at AVENUE THERAPEUTICS, INC..

Action: resigned
Role: Director

Exact text from the filing

each of Jaideep Gogtay, M.D. and E. Garrett Ingram, the two non-independent members of the Board originally selected by InvaGen, resigned as members of the Board and all committees thereof, effective immediately.

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

E. Garrett Ingram resigned as Director at AVENUE THERAPEUTICS, INC..

Action: resigned
Role: Director

Exact text from the filing

each of Jaideep Gogtay, M.D. and E. Garrett Ingram, the two non-independent members of the Board originally selected by InvaGen, resigned as members of the Board and all committees thereof, effective immediately.

View on SEC.gov

AVENUE THERAPEUTICS, INC. filing history →

Source: SEC EDGAR

accession 0001104659-22-114916

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.